Literature DB >> 28073675

Design, synthesis and biological evaluation of regioisomers of 666-15 as inhibitors of CREB-mediated gene transcription.

Fuchun Xie1, Bingbing X Li1, Xiangshu Xiao2.   

Abstract

cAMP-response element binding protein (CREB) is a nuclear transcription factor that has been implicated in the pathogenesis and maintenance of various types of human cancers. Identification of small molecule inhibitors of CREB-mediated gene transcription has been pursued as a novel strategy for developing cancer therapeutics. We recently discovered a potent and cell-permeable CREB inhibitor called 666-15. 666-15 is a bisnaphthamide and has been shown to possess efficacious anti-breast cancer activity without toxicity in vivo. In this study, we designed and synthesized a series of analogs of 666-15 to probe the importance of regiochemistry in naphthalene ring B. Biological evaluations of these analogs demonstrated that the substitution pattern of the alkoxy and carboxamide in naphthalene ring B is very critical for maintaining potent CREB inhibition activity, suggesting that the unique bioactive conformation accessible in 666-15 is critically important.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  666-15; Bioactive conformation; CREB; Cancer; Regioisomer

Mesh:

Substances:

Year:  2016        PMID: 28073675      PMCID: PMC5296214          DOI: 10.1016/j.bmcl.2016.12.078

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  26 in total

Review 1.  CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals.

Authors:  A J Shaywitz; M E Greenberg
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

2.  Identification, synthesis and evaluation of substituted benzofurazans as inhibitors of CREB-mediated gene transcription.

Authors:  Fuchun Xie; Bingbing X Li; Candice Broussard; Xiangshu Xiao
Journal:  Bioorg Med Chem Lett       Date:  2013-07-31       Impact factor: 2.823

Review 3.  Targeted therapies for breast cancer.

Authors:  Michaela J Higgins; José Baselga
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

4.  CREB is a novel nuclear target of PTEN phosphatase.

Authors:  Tingting Gu; Zhong Zhang; Jianli Wang; Junyi Guo; Wen Hong Shen; Yuxin Yin
Journal:  Cancer Res       Date:  2011-03-08       Impact factor: 12.701

5.  Novel Type of Prodrug Activation through a Long-Range O,N-Acyl Transfer: A Case of Water-Soluble CREB Inhibitor.

Authors:  Bingbing X Li; Fuchun Xie; Qiuhua Fan; Kerry M Barnhart; Curtis E Moore; Arnold L Rheingold; Xiangshu Xiao
Journal:  ACS Med Chem Lett       Date:  2014-08-22       Impact factor: 4.345

6.  Active CREB1 promotes a malignant TGFβ2 autocrine loop in glioblastoma.

Authors:  Laura Rodón; Alba Gonzàlez-Juncà; María del Mar Inda; Ada Sala-Hojman; Elena Martínez-Sáez; Joan Seoane
Journal:  Cancer Discov       Date:  2014-08-01       Impact factor: 39.397

7.  Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation.

Authors:  B E Wadzinski; W H Wheat; S Jaspers; L F Peruski; R L Lickteig; G L Johnson; D J Klemm
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

8.  A Novel Small-Molecule Inhibitor Targeting CREB-CBP Complex Possesses Anti-Cancer Effects along with Cell Cycle Regulation, Autophagy Suppression and Endoplasmic Reticulum Stress.

Authors:  Jong Woo Lee; Hee Sun Park; Sin-Aye Park; Seung-Hee Ryu; Wuyi Meng; Juliane M Jürgensmeier; Jonathan M Kurie; Waun Ki Hong; Julie L Boyer; Roy S Herbst; Ja Seok Koo
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

9.  Identification of a Potent Inhibitor of CREB-Mediated Gene Transcription with Efficacious in Vivo Anticancer Activity.

Authors:  Fuchun Xie; Bingbing X Li; Alina Kassenbrock; Changhui Xue; Xiaoyan Wang; David Z Qian; Rosalie C Sears; Xiangshu Xiao
Journal:  J Med Chem       Date:  2015-06-05       Impact factor: 7.446

Review 10.  Tumour heterogeneity and cancer cell plasticity.

Authors:  Corbin E Meacham; Sean J Morrison
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

View more
  5 in total

1.  Naringin Mediates Adult Hippocampal Neurogenesis for Antidepression via Activating CREB Signaling.

Authors:  Chong Gao; Meiling Wu; Qiaohui Du; Jiagang Deng; Jiangang Shen
Journal:  Front Cell Dev Biol       Date:  2022-04-07

Review 2.  What turns CREB on? And off? And why does it matter?

Authors:  André Steven; Michael Friedrich; Paul Jank; Nadine Heimer; Jan Budczies; Carsten Denkert; Barbara Seliger
Journal:  Cell Mol Life Sci       Date:  2020-04-28       Impact factor: 9.261

3.  Antiallergic drug desloratadine as a selective antagonist of 5HT2A receptor ameliorates pathology of Alzheimer's disease model mice by improving microglial dysfunction.

Authors:  Jian Lu; Chuzhao Zhang; Jianlu Lv; Xialin Zhu; Xingwu Jiang; Weiqiang Lu; Yin Lu; Zongxiang Tang; Jiaying Wang; Xu Shen
Journal:  Aging Cell       Date:  2020-12-24       Impact factor: 9.304

4.  SS18-SSX drives CREB activation in synovial sarcoma.

Authors:  Magdalene Cyra; Miriam Schulte; Ruth Berthold; Lorena Heinst; Esther-Pia Jansen; Inga Grünewald; Sandra Elges; Olle Larsson; Christoph Schliemann; Konrad Steinestel; Susanne Hafner; Thomas Simmet; Eva Wardelmann; Sareetha Kailayangiri; Claudia Rossig; Ilka Isfort; Marcel Trautmann; Wolfgang Hartmann
Journal:  Cell Oncol (Dordr)       Date:  2022-05-12       Impact factor: 7.051

5.  A suite of bioassays to evaluate CREB inhibitors.

Authors:  Bingbing X Li; Xiangshu Xiao
Journal:  Methods Enzymol       Date:  2019-11-22       Impact factor: 1.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.